Lazard Hires Omid Ahdieh To Healthcare Group As Managing Director

News & Announcements - Financial Advisory

Share

As part of Lazard's 2030 long-term growth strategy that includes adding new Managing Directors through internal promotion and lateral hiring, this week the firm welcomed Omid Ahdieh as a Managing Director in the Healthcare Group. This follows several important senior hires across the healthcare sector, including Rob Lowe, John Koski, Tim Anderson, Gabor Szabo, and Geoff Porges as Managing Directors, reflecting the firm's continued commitment to building one of the preeminent healthcare advisory practices in the industry.

Omid brings over 30 years of experience advising on strategic M&A and financing transactions across the healthcare services industry, with deep expertise in pharmaceutical services, pharma tech, and laboratories and clinical diagnostics. Over the course of his career, he has worked with many of the sector's most prominent companies and financial sponsors, including:

• Most recently a Managing Director at Bank of America, where he led the firm's global pharmaceutical services practice, advising on some of the most significant transactions in the sector.
• Previously served as Managing Director and Head of Healthcare at Wells Fargo, where he helped build and lead the firm's healthcare and corporate investment banking franchise.
• Earlier in his career, held senior roles at Wachovia and First Union, predecessor institutions to Wells Fargo, developing deep expertise and long-standing relationships across the healthcare services landscape.

"Omid is a deeply experienced advisor who has spent his career at the center of some of healthcare services' most significant transactions. He has built trusted relationships across leading companies and financial sponsors alike," said David Gluckman, Global Head of Healthcare at Lazard. "Healthcare services leadership teams, boards, and investors are navigating a period of meaningful change - driven by evolving policy, shifting capital markets conditions, and accelerating technological change. His addition to our team expands our footprint in pharmaceutical services, pharma tech, and clinical diagnostics, and enhances our ability to help clients identify opportunities and manage the challenges of a rapidly changing competitive landscape."

Omid holds a Bachelor of Science in Health Policy and Management from the University of North Carolina at Chapel Hill (School of Global Public Health).

About Lazard

Founded in 1848, Lazard is the preeminent financial advisory and asset management firm, with operations in North and South America, Europe, the Middle East, Asia, and Australia. Lazard provides advice on mergers and acquisitions, capital markets and capital solutions, restructuring and liability management, geopolitics, and other strategic matters, as well as asset management and investment solutions to institutions, corporations, governments, partnerships, family offices, and high net worth individuals. Lazard is listed on the New York Stock Exchange as Lazard, Inc. under the ticker LAZ. For more information, please visit Lazard.com and follow Lazard on LinkedIn.